Recurrent systemic pneumococcal disease in children

Edward O Mason1, Ellen R Wald, Tina Q Tan

  • 1Pediatric Infectious Disease Section, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas 77030, USA. emason@bcm.edu

Insights

Recurrent invasive pneumococcal disease (IPD) in children often indicates underlying conditions. Most recurrent IPD cases are caused by new bacterial strains, not relapses.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Recurrent systemic pneumococcal infection is uncommon, typically affecting immunocompromised individuals or those with pre-existing health issues.
  • Understanding the characteristics and causes of recurrent invasive pneumococcal disease (IPD) is crucial for effective management.

Purpose of the Study:

  • To investigate the incidence, clinical features, and causative agents of recurrent invasive pneumococcal disease (IPD) in a pediatric population.
  • To differentiate between true reinfection and relapse in cases of recurrent IPD.

Main Methods:

  • Prospective identification and retrospective data collection of invasive pneumococcal disease (IPD) cases across 8 pediatric hospitals from 1993 to 2006.
  • Serotyping of Streptococcus pneumoniae isolates and molecular typing using pulse-field gel electrophoresis (PFGE) to determine strain relatedness.
  • Antibiotic susceptibility testing for penicillin and ceftriaxone.

Main Results:

  • Out of 4,067 children diagnosed with IPD, 90 (2.6%) experienced 108 episodes of recurrent disease over 12.3 years.
  • The majority of children with recurrent IPD (approximately 80%) had underlying medical conditions.
  • In 70 episodes, recurrent IPD was caused by a different serotype or genotype (PFGE pattern), suggesting new infections rather than relapses.

Conclusions:

  • Recurrent invasive pneumococcal disease in children is strongly associated with underlying health conditions.
  • A significant proportion of short-interval recurrent infections (<30 days) were attributed to new strain acquisition.
  • Distinguishing between relapse and reinfection in recurrent IPD necessitates confirming identical serotype and PFGE patterns of the causative pneumococcal isolates.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...